Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause severe placental lesions leading rapidly to intrauterine fetal death (IUFD). From August 2020 to September 2021, in the pathology department of Toulouse Oncopole, we analyzed 50 placentas from COVID-19–positive unvaccin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human pathology 2022-03, Vol.121, p.46-55
Hauptverfasser: Dubucs, Charlotte, Groussolles, Marion, Ousselin, Jessie, Sartor, Agnès, Van Acker, Nathalie, Vayssière, Christophe, Pasquier, Christophe, Reyre, Joëlle, Batlle, Laïa, Favarel clinical research associate, Stèphanie, Duchanois midwife, Delphine, Jauffret clinical research associate, Valèrie, Courtade-Saïdi, Monique, Aziza, Jacqueline
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 55
container_issue
container_start_page 46
container_title Human pathology
container_volume 121
creator Dubucs, Charlotte
Groussolles, Marion
Ousselin, Jessie
Sartor, Agnès
Van Acker, Nathalie
Vayssière, Christophe
Pasquier, Christophe
Reyre, Joëlle
Batlle, Laïa
Favarel clinical research associate, Stèphanie
Duchanois midwife, Delphine
Jauffret clinical research associate, Valèrie
Courtade-Saïdi, Monique
Aziza, Jacqueline
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause severe placental lesions leading rapidly to intrauterine fetal death (IUFD). From August 2020 to September 2021, in the pathology department of Toulouse Oncopole, we analyzed 50 placentas from COVID-19–positive unvaccinated mothers. The purpose of our study is to describe the clinicopathological characteristics of these placental damages and to understand the pathophysiology. Ten of them (20%) showed placental lesions with positive immunohistochemistry for SARS-CoV-2 in villous trophoblasts. In five cases (10%), we observed massive placental damage associating trophoblastic necrosis, fibrinous deposits, intervillositis, as well as extensive hemorrhagic changes due to SARS-CoV-2 infection probably responsible of IUFD by functional placental insufficiency. In five other cases, we found similar placental lesions but with a focal distribution that did not lead to IUFD but live birth. These lesions are independent of maternal clinical severity of COVID-19 infection because they occur despite mild maternal symptoms and are therefore difficult to predict. In our cases, they occurred 1–3 weeks after positive SARS-CoV-2 maternal real-time polymerase chain reaction testing and were observed in the 2nd and 3rd trimesters of pregnancies. When these lesions are focal, they do not lead to IUFD and can be involved in intrauterine growth restriction. Our findings, together with recent observations, suggest that future pregnancy guidance should include stricter pandemic precautions such as screening for a wider array of COVID-19 symptoms, enhanced ultrasound monitoring, as well as newborn medical surveillance. •Maternal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can generate severe placental lesions.•Some COVID-19–positive unvaccinated mothers show trophoblastic necrosis with positive anti-SARS-CoV-2 immunohistochemitrsy.•SARS-CoV-2 placental lesions can be involved in intrauterine fetal death (10% of cases) when placental damage is massive.•Intrauterine fetal death occurred 1–3 weeks after maternal infection in 2nd and 3rd trimesters of pregnancies.•Severe SARS-CoV-2 placenta lesions occur despite mild maternal COVID-19 symptoms.
doi_str_mv 10.1016/j.humpath.2021.12.012
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8730375</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0046817721002203</els_id><sourcerecordid>2638967296</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-3c8d70b67d1ede984c795968f53c37a6377ca021602a59efc126df44ab056a803</originalsourceid><addsrcrecordid>eNqFkV2LEzEUhoMobnf1JygD3rgXM-Zj8nWjlKKuUBCsehvS5IxNmU5qMlPw35uhddG98Spw8pz3nPe8CL0guCGYiDf7ZjcdjnbcNRRT0hDaYEIfoQXhjNaKafoYLTBuRa2IlFfoOuc9xoTwlj9FV6zVmgvZLpDfwAkSVMfeOhhG21c95BCHXPkJqjFWBztCGkp9s_yyqVfxe02rMHTgxkJVNufoQkH8zIZhTHYqfBig6mBW81BWfIaedLbP8Pzy3qBvH95_Xd3V688fP62W69pxqseaOeUl3grpCXjQqnVScy1Ux5lj0gompbPFrMDUcg2dI1T4rm3tFnNhFWY36O1Z9zhtD-BnQ8n25pjCwaZfJtpg_v0Zws78iCejJMNM8iJwexbYPWi7W67NXMMt51wpdSKFfX0ZluLPCfJoDiE76Hs7QJyyoYIoyrDgbUFfPUD3cZqPOlNMaSGpFoXiZ8qlmHOC7n4Dgs2cudmbS-ZmztwQakrmpe_l367vu_6EXIB3ZwDK7U8BkskuwODAh1RyND6G_4z4DU5Rv-c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2638967296</pqid></control><display><type>article</type><title>Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Dubucs, Charlotte ; Groussolles, Marion ; Ousselin, Jessie ; Sartor, Agnès ; Van Acker, Nathalie ; Vayssière, Christophe ; Pasquier, Christophe ; Reyre, Joëlle ; Batlle, Laïa ; Favarel clinical research associate, Stèphanie ; Duchanois midwife, Delphine ; Jauffret clinical research associate, Valèrie ; Courtade-Saïdi, Monique ; Aziza, Jacqueline</creator><creatorcontrib>Dubucs, Charlotte ; Groussolles, Marion ; Ousselin, Jessie ; Sartor, Agnès ; Van Acker, Nathalie ; Vayssière, Christophe ; Pasquier, Christophe ; Reyre, Joëlle ; Batlle, Laïa ; Favarel clinical research associate, Stèphanie ; Duchanois midwife, Delphine ; Jauffret clinical research associate, Valèrie ; Courtade-Saïdi, Monique ; Aziza, Jacqueline</creatorcontrib><description>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause severe placental lesions leading rapidly to intrauterine fetal death (IUFD). From August 2020 to September 2021, in the pathology department of Toulouse Oncopole, we analyzed 50 placentas from COVID-19–positive unvaccinated mothers. The purpose of our study is to describe the clinicopathological characteristics of these placental damages and to understand the pathophysiology. Ten of them (20%) showed placental lesions with positive immunohistochemistry for SARS-CoV-2 in villous trophoblasts. In five cases (10%), we observed massive placental damage associating trophoblastic necrosis, fibrinous deposits, intervillositis, as well as extensive hemorrhagic changes due to SARS-CoV-2 infection probably responsible of IUFD by functional placental insufficiency. In five other cases, we found similar placental lesions but with a focal distribution that did not lead to IUFD but live birth. These lesions are independent of maternal clinical severity of COVID-19 infection because they occur despite mild maternal symptoms and are therefore difficult to predict. In our cases, they occurred 1–3 weeks after positive SARS-CoV-2 maternal real-time polymerase chain reaction testing and were observed in the 2nd and 3rd trimesters of pregnancies. When these lesions are focal, they do not lead to IUFD and can be involved in intrauterine growth restriction. Our findings, together with recent observations, suggest that future pregnancy guidance should include stricter pandemic precautions such as screening for a wider array of COVID-19 symptoms, enhanced ultrasound monitoring, as well as newborn medical surveillance. •Maternal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can generate severe placental lesions.•Some COVID-19–positive unvaccinated mothers show trophoblastic necrosis with positive anti-SARS-CoV-2 immunohistochemitrsy.•SARS-CoV-2 placental lesions can be involved in intrauterine fetal death (10% of cases) when placental damage is massive.•Intrauterine fetal death occurred 1–3 weeks after maternal infection in 2nd and 3rd trimesters of pregnancies.•Severe SARS-CoV-2 placenta lesions occur despite mild maternal COVID-19 symptoms.</description><identifier>ISSN: 0046-8177</identifier><identifier>EISSN: 1532-8392</identifier><identifier>DOI: 10.1016/j.humpath.2021.12.012</identifier><identifier>PMID: 34995674</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Antibodies ; Births ; Coronaviruses ; COVID-19 ; COVID-19 - complications ; COVID-19 placental lesions ; Disease transmission ; Female ; Fetal Death - etiology ; Humans ; Infant, Newborn ; Infections ; Intrauterine fetal death ; Life Sciences ; Miscarriage ; Original Contribution ; Placenta ; Placenta - pathology ; Polymerase chain reaction ; Pregnancy ; Pregnancy Complications, Infectious - pathology ; SARS-CoV-2 ; SARS-Cov-2 infection ; Severe acute respiratory syndrome coronavirus 2</subject><ispartof>Human pathology, 2022-03, Vol.121, p.46-55</ispartof><rights>2022 Elsevier Inc.</rights><rights>Copyright © 2022 Elsevier Inc. All rights reserved.</rights><rights>2022. Elsevier Inc.</rights><rights>Attribution - NonCommercial</rights><rights>2022 Elsevier Inc. All rights reserved. 2022 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-3c8d70b67d1ede984c795968f53c37a6377ca021602a59efc126df44ab056a803</citedby><cites>FETCH-LOGICAL-c529t-3c8d70b67d1ede984c795968f53c37a6377ca021602a59efc126df44ab056a803</cites><orcidid>0000-0003-0420-5081 ; 0000-0003-2371-4113 ; 0000-0002-3745-4044</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.humpath.2021.12.012$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34995674$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://ut3-toulouseinp.hal.science/hal-04555888$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Dubucs, Charlotte</creatorcontrib><creatorcontrib>Groussolles, Marion</creatorcontrib><creatorcontrib>Ousselin, Jessie</creatorcontrib><creatorcontrib>Sartor, Agnès</creatorcontrib><creatorcontrib>Van Acker, Nathalie</creatorcontrib><creatorcontrib>Vayssière, Christophe</creatorcontrib><creatorcontrib>Pasquier, Christophe</creatorcontrib><creatorcontrib>Reyre, Joëlle</creatorcontrib><creatorcontrib>Batlle, Laïa</creatorcontrib><creatorcontrib>Favarel clinical research associate, Stèphanie</creatorcontrib><creatorcontrib>Duchanois midwife, Delphine</creatorcontrib><creatorcontrib>Jauffret clinical research associate, Valèrie</creatorcontrib><creatorcontrib>Courtade-Saïdi, Monique</creatorcontrib><creatorcontrib>Aziza, Jacqueline</creatorcontrib><title>Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death</title><title>Human pathology</title><addtitle>Hum Pathol</addtitle><description>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause severe placental lesions leading rapidly to intrauterine fetal death (IUFD). From August 2020 to September 2021, in the pathology department of Toulouse Oncopole, we analyzed 50 placentas from COVID-19–positive unvaccinated mothers. The purpose of our study is to describe the clinicopathological characteristics of these placental damages and to understand the pathophysiology. Ten of them (20%) showed placental lesions with positive immunohistochemistry for SARS-CoV-2 in villous trophoblasts. In five cases (10%), we observed massive placental damage associating trophoblastic necrosis, fibrinous deposits, intervillositis, as well as extensive hemorrhagic changes due to SARS-CoV-2 infection probably responsible of IUFD by functional placental insufficiency. In five other cases, we found similar placental lesions but with a focal distribution that did not lead to IUFD but live birth. These lesions are independent of maternal clinical severity of COVID-19 infection because they occur despite mild maternal symptoms and are therefore difficult to predict. In our cases, they occurred 1–3 weeks after positive SARS-CoV-2 maternal real-time polymerase chain reaction testing and were observed in the 2nd and 3rd trimesters of pregnancies. When these lesions are focal, they do not lead to IUFD and can be involved in intrauterine growth restriction. Our findings, together with recent observations, suggest that future pregnancy guidance should include stricter pandemic precautions such as screening for a wider array of COVID-19 symptoms, enhanced ultrasound monitoring, as well as newborn medical surveillance. •Maternal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can generate severe placental lesions.•Some COVID-19–positive unvaccinated mothers show trophoblastic necrosis with positive anti-SARS-CoV-2 immunohistochemitrsy.•SARS-CoV-2 placental lesions can be involved in intrauterine fetal death (10% of cases) when placental damage is massive.•Intrauterine fetal death occurred 1–3 weeks after maternal infection in 2nd and 3rd trimesters of pregnancies.•Severe SARS-CoV-2 placenta lesions occur despite mild maternal COVID-19 symptoms.</description><subject>Antibodies</subject><subject>Births</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - complications</subject><subject>COVID-19 placental lesions</subject><subject>Disease transmission</subject><subject>Female</subject><subject>Fetal Death - etiology</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Infections</subject><subject>Intrauterine fetal death</subject><subject>Life Sciences</subject><subject>Miscarriage</subject><subject>Original Contribution</subject><subject>Placenta</subject><subject>Placenta - pathology</subject><subject>Polymerase chain reaction</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - pathology</subject><subject>SARS-CoV-2</subject><subject>SARS-Cov-2 infection</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><issn>0046-8177</issn><issn>1532-8392</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV2LEzEUhoMobnf1JygD3rgXM-Zj8nWjlKKuUBCsehvS5IxNmU5qMlPw35uhddG98Spw8pz3nPe8CL0guCGYiDf7ZjcdjnbcNRRT0hDaYEIfoQXhjNaKafoYLTBuRa2IlFfoOuc9xoTwlj9FV6zVmgvZLpDfwAkSVMfeOhhG21c95BCHXPkJqjFWBztCGkp9s_yyqVfxe02rMHTgxkJVNufoQkH8zIZhTHYqfBig6mBW81BWfIaedLbP8Pzy3qBvH95_Xd3V688fP62W69pxqseaOeUl3grpCXjQqnVScy1Ux5lj0gompbPFrMDUcg2dI1T4rm3tFnNhFWY36O1Z9zhtD-BnQ8n25pjCwaZfJtpg_v0Zws78iCejJMNM8iJwexbYPWi7W67NXMMt51wpdSKFfX0ZluLPCfJoDiE76Hs7QJyyoYIoyrDgbUFfPUD3cZqPOlNMaSGpFoXiZ8qlmHOC7n4Dgs2cudmbS-ZmztwQakrmpe_l367vu_6EXIB3ZwDK7U8BkskuwODAh1RyND6G_4z4DU5Rv-c</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Dubucs, Charlotte</creator><creator>Groussolles, Marion</creator><creator>Ousselin, Jessie</creator><creator>Sartor, Agnès</creator><creator>Van Acker, Nathalie</creator><creator>Vayssière, Christophe</creator><creator>Pasquier, Christophe</creator><creator>Reyre, Joëlle</creator><creator>Batlle, Laïa</creator><creator>Favarel clinical research associate, Stèphanie</creator><creator>Duchanois midwife, Delphine</creator><creator>Jauffret clinical research associate, Valèrie</creator><creator>Courtade-Saïdi, Monique</creator><creator>Aziza, Jacqueline</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><general>WB Saunders</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0420-5081</orcidid><orcidid>https://orcid.org/0000-0003-2371-4113</orcidid><orcidid>https://orcid.org/0000-0002-3745-4044</orcidid></search><sort><creationdate>20220301</creationdate><title>Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death</title><author>Dubucs, Charlotte ; Groussolles, Marion ; Ousselin, Jessie ; Sartor, Agnès ; Van Acker, Nathalie ; Vayssière, Christophe ; Pasquier, Christophe ; Reyre, Joëlle ; Batlle, Laïa ; Favarel clinical research associate, Stèphanie ; Duchanois midwife, Delphine ; Jauffret clinical research associate, Valèrie ; Courtade-Saïdi, Monique ; Aziza, Jacqueline</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-3c8d70b67d1ede984c795968f53c37a6377ca021602a59efc126df44ab056a803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies</topic><topic>Births</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - complications</topic><topic>COVID-19 placental lesions</topic><topic>Disease transmission</topic><topic>Female</topic><topic>Fetal Death - etiology</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Infections</topic><topic>Intrauterine fetal death</topic><topic>Life Sciences</topic><topic>Miscarriage</topic><topic>Original Contribution</topic><topic>Placenta</topic><topic>Placenta - pathology</topic><topic>Polymerase chain reaction</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - pathology</topic><topic>SARS-CoV-2</topic><topic>SARS-Cov-2 infection</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dubucs, Charlotte</creatorcontrib><creatorcontrib>Groussolles, Marion</creatorcontrib><creatorcontrib>Ousselin, Jessie</creatorcontrib><creatorcontrib>Sartor, Agnès</creatorcontrib><creatorcontrib>Van Acker, Nathalie</creatorcontrib><creatorcontrib>Vayssière, Christophe</creatorcontrib><creatorcontrib>Pasquier, Christophe</creatorcontrib><creatorcontrib>Reyre, Joëlle</creatorcontrib><creatorcontrib>Batlle, Laïa</creatorcontrib><creatorcontrib>Favarel clinical research associate, Stèphanie</creatorcontrib><creatorcontrib>Duchanois midwife, Delphine</creatorcontrib><creatorcontrib>Jauffret clinical research associate, Valèrie</creatorcontrib><creatorcontrib>Courtade-Saïdi, Monique</creatorcontrib><creatorcontrib>Aziza, Jacqueline</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Human pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dubucs, Charlotte</au><au>Groussolles, Marion</au><au>Ousselin, Jessie</au><au>Sartor, Agnès</au><au>Van Acker, Nathalie</au><au>Vayssière, Christophe</au><au>Pasquier, Christophe</au><au>Reyre, Joëlle</au><au>Batlle, Laïa</au><au>Favarel clinical research associate, Stèphanie</au><au>Duchanois midwife, Delphine</au><au>Jauffret clinical research associate, Valèrie</au><au>Courtade-Saïdi, Monique</au><au>Aziza, Jacqueline</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death</atitle><jtitle>Human pathology</jtitle><addtitle>Hum Pathol</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>121</volume><spage>46</spage><epage>55</epage><pages>46-55</pages><issn>0046-8177</issn><eissn>1532-8392</eissn><abstract>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause severe placental lesions leading rapidly to intrauterine fetal death (IUFD). From August 2020 to September 2021, in the pathology department of Toulouse Oncopole, we analyzed 50 placentas from COVID-19–positive unvaccinated mothers. The purpose of our study is to describe the clinicopathological characteristics of these placental damages and to understand the pathophysiology. Ten of them (20%) showed placental lesions with positive immunohistochemistry for SARS-CoV-2 in villous trophoblasts. In five cases (10%), we observed massive placental damage associating trophoblastic necrosis, fibrinous deposits, intervillositis, as well as extensive hemorrhagic changes due to SARS-CoV-2 infection probably responsible of IUFD by functional placental insufficiency. In five other cases, we found similar placental lesions but with a focal distribution that did not lead to IUFD but live birth. These lesions are independent of maternal clinical severity of COVID-19 infection because they occur despite mild maternal symptoms and are therefore difficult to predict. In our cases, they occurred 1–3 weeks after positive SARS-CoV-2 maternal real-time polymerase chain reaction testing and were observed in the 2nd and 3rd trimesters of pregnancies. When these lesions are focal, they do not lead to IUFD and can be involved in intrauterine growth restriction. Our findings, together with recent observations, suggest that future pregnancy guidance should include stricter pandemic precautions such as screening for a wider array of COVID-19 symptoms, enhanced ultrasound monitoring, as well as newborn medical surveillance. •Maternal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can generate severe placental lesions.•Some COVID-19–positive unvaccinated mothers show trophoblastic necrosis with positive anti-SARS-CoV-2 immunohistochemitrsy.•SARS-CoV-2 placental lesions can be involved in intrauterine fetal death (10% of cases) when placental damage is massive.•Intrauterine fetal death occurred 1–3 weeks after maternal infection in 2nd and 3rd trimesters of pregnancies.•Severe SARS-CoV-2 placenta lesions occur despite mild maternal COVID-19 symptoms.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34995674</pmid><doi>10.1016/j.humpath.2021.12.012</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-0420-5081</orcidid><orcidid>https://orcid.org/0000-0003-2371-4113</orcidid><orcidid>https://orcid.org/0000-0002-3745-4044</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0046-8177
ispartof Human pathology, 2022-03, Vol.121, p.46-55
issn 0046-8177
1532-8392
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8730375
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Antibodies
Births
Coronaviruses
COVID-19
COVID-19 - complications
COVID-19 placental lesions
Disease transmission
Female
Fetal Death - etiology
Humans
Infant, Newborn
Infections
Intrauterine fetal death
Life Sciences
Miscarriage
Original Contribution
Placenta
Placenta - pathology
Polymerase chain reaction
Pregnancy
Pregnancy Complications, Infectious - pathology
SARS-CoV-2
SARS-Cov-2 infection
Severe acute respiratory syndrome coronavirus 2
title Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T12%3A17%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Severe%20placental%20lesions%20due%20to%20maternal%20SARS-CoV-2%20infection%20associated%20to%20intrauterine%20fetal%20death&rft.jtitle=Human%20pathology&rft.au=Dubucs,%20Charlotte&rft.date=2022-03-01&rft.volume=121&rft.spage=46&rft.epage=55&rft.pages=46-55&rft.issn=0046-8177&rft.eissn=1532-8392&rft_id=info:doi/10.1016/j.humpath.2021.12.012&rft_dat=%3Cproquest_pubme%3E2638967296%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2638967296&rft_id=info:pmid/34995674&rft_els_id=S0046817721002203&rfr_iscdi=true